Colgate's Resilient Quarter Hides a U.S. Soft Spot
Broad-based growth, margin expansion, and an ambitious fresh pet-food launch mask a candid admission of North American weakness
CL · Earnings Call · 2026-07-31
A Quarter of Resilience
The headline for Colgate-Palmolive (CL) in Q2 2026 is resilience. In a world of tariff volatility, geopolitical tension, and uneven consumer confidence, the company delivered what management called "another quarter of strong top and bottom line growth." Organic sales were up in 4 of 5 divisions and 3 of 4 categories, with emerging markets – India, Brazil, Mexico, and China – leading the way. Gross margin expanded 100 basis points year-over-year, and advertising rose double-digits, funded by productivity gains and a modest tariff refund benefit. Free cash flow was up 18%, and the company returned $1.4 billion to shareholders. The stock has responded: over the past 90 days, CL is up 8% and sits within 4% of its recent high, suggesting investors are buying the story of a company that can navigate turbulence. Gross margin ended Q1 2026 at 60.6%, down just 0.2pp year-over-year but still near the top of its historical range. The long-term upward trend – from 60% in 2016 to over 61% in recent quarters – underscores the durability of the company's pricing power and cost discipline, even as inflation and tariffs pressure the P&L.The U.S. Drag: A Tale of Two Markets
Yet the quarter also exposed a fault line: North America. Management was uncharacteristically blunt: "Clearly, we're all particularly the North America group, disappointed with the second quarter." The weakness was driven by a confluence of category softness, competitive pressure, and inventory reductions by key retailers. Shipments outpaced consumption by roughly 3 points, a gap that management attributes to destocking. Accelerated innovation, targeted pricing, and stepped-up brand support are the levers being pulled to reverse the slide. As the CEO put it, "We're going to be very intentional. We recognize that the numbers aren't where they need to be. It won't be a linear improvement, but we'll see certainly sequential improvement as we move through the back half of the year." This candid assessment, coupled with a plan that includes brand support and a sharper focus on the premium side of the portfolio, signals that the company is not complacent. The U.S. is not the only area of concern. consumer confidence — a recurring theme in the call — remains fragile, and management was careful to temper expectations for a swift rebound. Still, the fact that the company is willing to call out the problem and outline concrete actions differentiates this from a purely defensive posture.Hill's Fresh: Betting on Science
Perhaps the most strategically significant development is the ramp of Hill's Fresh, the single-protein refrigerated pet food line launched via the Prime acquisition. Management is deliberate in its approach: "We're not looking to generate significant volume right now. We're looking to really build the brand and underscore the science-driven nature of our product." The launch is anchored on three single-protein diets, backed by veterinary endorsements and a manufacturing process refined over the past year. This is a low-volume, high-credibility play designed to reinforce Hill's science-based positioning. The broader Hill's business continues to outperform a flat category, with therapeutic and wet segments the standouts, but the Fresh initiative could open a new premium aisle for the company.We believe there's real science behind it. We're focused on getting the profession to underscore the importance of the quality of these products and the efficacy values they bring.